These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 215521)

  • 21. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
    Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
    J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
    Fujiwara S; Takada K; Yano S; Osato T
    Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies.
    Sternås L; Luka J; Kallin B; Rosén A; Henle W; Henle G; Klein G
    J Immunol Methods; 1983 Oct; 63(2):171-85. PubMed ID: 6311908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies on EBV antigens by immunofluorescence and immunoperoxidase techniques.
    Stephens R; Traul K; Gaudreau P; Yeh J; Fisher L; Mayyasi SA
    Int J Cancer; 1977 Mar; 19(3):305-16. PubMed ID: 66208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen.
    Dölken G; Boldt C; Lange W; Weitzmann U; Löhr GW; Rosén A
    Cancer Detect Prev; 1983; 6(1-2):287-92. PubMed ID: 6309387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
    Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL
    IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
    Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH
    J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
    Coker-Vann M; Dolin R
    J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains.
    Dölken G; Klein G
    Virology; 1976 Mar; 70(1):210-3. PubMed ID: 176804
    [No Abstract]   [Full Text] [Related]  

  • 30. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide.
    Mueller-Lantzsch N; Yamamoto N
    J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.
    Shimakage M; Ikegami N; Chatani M; Yoshino K; Sato T
    Biken J; 1987 Jun; 30(2):45-51. PubMed ID: 2830879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
    Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon enhances the expression of epstein-Barr virus early antigen in Daudi cells.
    Tovey MG; Dron M; Gresser I
    J Gen Virol; 1982 May; 60(Pt 1):31-8. PubMed ID: 6178801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms.
    Kurakata S; Ramos OF; Klein G; Klein E
    Cell Immunol; 1989 Oct; 123(1):134-47. PubMed ID: 2550147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.
    Patel PC; Menezes J
    Clin Exp Immunol; 1982 Jun; 48(3):589-601. PubMed ID: 6288292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel surface antigen on lymphoid cells transformed by Epstein-Barr virus.
    Hinuma Y; Sakamoto K
    IARC Sci Publ (1971); 1978; (24 Pt 1):249-51. PubMed ID: 87368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of 1-beta-D-arabinofuranosylthymine on synthesis of Epstein-Barr virus.
    Yonemura K; Sairenji T; Hinuma Y
    Microbiol Immunol; 1981; 25(6):557-63. PubMed ID: 6268944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
    Takada K; Fujiwara S; Yano S; Osato T
    Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of mitomycin C and hydroxyurea on the expression of the Epstein-Barr virus cycle following P3HR-1 superinfection.
    Moar MH; Klein G
    Intervirology; 1980; 13(3):178-85. PubMed ID: 6246034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).
    de Schryver A; Klein G; Hewetson J; Rocchi G; Henle W; Henle G; Moss DJ; Pope JH
    Int J Cancer; 1974 Mar; 13(3):353-62. PubMed ID: 4362610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.